Abstract
The use of aptamers as targeting molecules has revolutionized nanomedicine. Aptamers are short oligonucleotides or peptides that can be used as targeting ligands against numerous targets. Aptamers are versatile moieties that can be used both in therapeutic and targeting applications. Aptamers bind to the target in a process that is similar to the lock and key mechanism. There are numerous reports on the use of aptamers as targeting moieties for imaging and drug delivery applications. In this review, we would like to give a comprehensive report on aptamers, its properties and the developments in aptamer mediated drug delivery in the recent years.
Keywords: Nanomedicine, Aptamers, Targeting, Nanotherapy.
Graphical Abstract
Current Topics in Medicinal Chemistry
Title:Aptamers in Targeted Nanotherapy
Volume: 15 Issue: 12
Author(s): Anila Mathew, Toru Maekawa and D. Sakthikumar
Affiliation:
Keywords: Nanomedicine, Aptamers, Targeting, Nanotherapy.
Abstract: The use of aptamers as targeting molecules has revolutionized nanomedicine. Aptamers are short oligonucleotides or peptides that can be used as targeting ligands against numerous targets. Aptamers are versatile moieties that can be used both in therapeutic and targeting applications. Aptamers bind to the target in a process that is similar to the lock and key mechanism. There are numerous reports on the use of aptamers as targeting moieties for imaging and drug delivery applications. In this review, we would like to give a comprehensive report on aptamers, its properties and the developments in aptamer mediated drug delivery in the recent years.
Export Options
About this article
Cite this article as:
Mathew Anila, Maekawa Toru and Sakthikumar D., Aptamers in Targeted Nanotherapy, Current Topics in Medicinal Chemistry 2015; 15 (12) . https://dx.doi.org/10.2174/1568026615666150413153525
DOI https://dx.doi.org/10.2174/1568026615666150413153525 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Roles of Sox Family Genes in Sarcoma
Current Drug Targets T Cell Suicide Gene Therapy to Aid Haematopoietic Stem Cell Transplantation
Current Gene Therapy Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Dual Receptor-Specific Peptides Modified Liposomes as VEGF siRNA Vector for Tumor-Targeting Therapy
Current Gene Therapy Medicinal Plants for Glioblastoma Treatment
Anti-Cancer Agents in Medicinal Chemistry Considering Autotaxin Inhibitors in Terms of 2D-QSAR and 3D-Mapping- Review and Evaluation
Current Medicinal Chemistry Meet Our Associate Editor
Current Molecular Medicine Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents
Current Topics in Medicinal Chemistry Apoptosis in Drug Response
Current Pharmacogenomics <sup>177</sup>Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
Current Radiopharmaceuticals Novel and Emerging Drugs for Acute Lymphoblastic Leukemia
Current Cancer Drug Targets Drug Delivery Systems and Strategies to Overcome the Barriers of Brain
Current Pharmaceutical Design CD248: Reviewing its Role in Health and Disease
Current Drug Targets Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy Infringement of the Barriers of Cancer Via Dietary Phytoconstituents Capsaicin Through Novel Drug Delivery System
Current Drug Delivery Current Status of Leukemia Cytotherapy - Exploitation with Immune Cells
Current Stem Cell Research & Therapy Anticarcinogenic Actions of Tributyrin, A Butyric Acid Prodrug
Current Drug Targets Long Non-Coding RNAs As Epigenetic Regulators in Cancer
Current Pharmaceutical Design Activity Based Chemical Proteomics: Profiling Proteases as Drug Targets
Current Drug Discovery Technologies Cannabinoids, Immune System and Cytokine Network
Current Pharmaceutical Design